Optimisation of Antibiotic Prescription in Acute Noncomplicated Respiratory Tract Infections in Children (OptimAP Study) (OptimAP)
Acute Respiratory Tract Infections
About this trial
This is an interventional treatment trial for Acute Respiratory Tract Infections focused on measuring Acute respiratory tract infection, Microbial Antibiotic Resistance, Communication skills training, Mobile app-based health information and education
Eligibility Criteria
Inclusion Criteria:
- Healthcare professionals who care for children in primary care centres and community pharmacists of reference in four Autonomous Communities of Spain (Catalonia, Balearic Islands, Navarra and Basque Country).
Exclusion Criteria:
- None
Sites / Locations
- Osakidetza - Ambulatorio de Pasai San Pedro
- Institut d'Investigació de les Illes Balears (IdISBa)
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Servicio Navarro de Salud - Osasunbidea
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
No Intervention
Intervention targeted to healthcare providers (paediatricians, nurses and pharmacists) (ITHP)
Intervention targeted to parents (ITP)
Intervention targeted to patients and/or patient´s parents and to the healthcare providers (ITHP*P)
Control group
Professionals in the PC centres allocated to this group will receive a complex intervention, delivered remotely, which will include the following components: i) Web based training that will include: communication skills training and optimal management of acute non-complicated RTI, including a specific training on delayed antibiotic prescription. ii) By-monthly feedback about the rate of antibiotic prescription and consumption for RTI, center level and individual pediatrician level (information automatically gathered from electronic health records).
PC centres allocated to this group will display posters and flyers to inform parents and/or caregivers about a mobile app. It will provide detailed information about respiratory tract infections and optimal use of antibiotics. The app will include information that will be of use before the consultation, but it will also allow the patient to interact with the physician during the consultation, potentially improving share decision-making. Importantly, the app will allow tailoring the guidance provided according to the type of infection or number of days with symptoms. The app will be accessible through an app store or directly using a QR (quick response) code to facilitate uptake. Professionals in the primary care centres allocated to this group will also receive a by-monthly feedback about the rate of antibiotic prescription and consumption for RTI, at center level and individual pediatrician level (information automatically gathered from electronic health records).
Centres allocated to this group will receive the two interventions described above (intervention targeted to parents plus intervention targeted to providers).
The centers allocated to this arm of the study will continue with their usual care. To avoid a potential Hawthorne effect (observer effect) these centers will not be informed about their participation as controls.